Clinical Trials · NCT00172185

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Name: Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Teduglutide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Shire
Enrollment: 65
Start date: Jan 2005
Locations: 21 sites, 8 countries
Primary endpoint: Number of Subjects Achieving a 20% Reduction at Week 28

View Teduglutide compound reference